遗传 ›› 2011, Vol. 33 ›› Issue (5): 469-484.doi: 10.3724/SP.J.1005.2011.00469
林福玉, 杨晓
收稿日期:2010-10-28
修回日期:2011-03-15
出版日期:2011-05-20
发布日期:2011-05-25
通讯作者:
杨晓
E-mail:yangx@nic.bmi.ac.cn
基金资助:蛋白质组学国家重点实验室深入研究课题(编号：SKLP-K200902), 国家科技重大专项新药创制(编号：2009ZX09501-027)资助
LIN Fu-Yu, YANG Xiao
Received:2010-10-28
Revised:2011-03-15
Online:2011-05-20
Published:2011-05-25
Contact:
YANG Xiao
E-mail:yangx@nic.bmi.ac.cn
林福玉，杨晓. 条件基因打靶研究存在的主要问题及对策[J]. 遗传, 2011, 33(5): 469-484.
LIN Fu-Yu, YANG Xiao. Issues and solutions of conditional gene targeting[J]. HEREDITAS, 2011, 33(5): 469-484.
| [1] Glaser S, Anastassiadis K, Stewart AF. Current issues in mouse genome engineering. Nat Genet, 2005, 37(11): 1187-1193.[2] Branda CS, Dymecki SM. Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice. Dev Cell, 2004, 6(1): 7-28.[3] Rajewsky K, Gu H, Kühn R, Betz UA, Müller W, Roes J, Schwenk F. Conditional gene targeting. J Clin Invest, 1996, 98(3): 600-603.[4] Schmidt-Supprian M, Rajewsky K. Vagaries of conditional gene targeting. Nat Immunol, 2007, 8(7): 665-668.[5] Matthaei KI. Genetically manipulated mice: a powerful tool with unsuspected caveats. J Physiol, 2007, 582(Pt 2): 481-488.[6] Holzenberger M, Lenzner C, Leneuve P, Zaoui R, Hamard G, Vaulont S, Bouc YL. Cre-mediated germline mosaicism: a method allowing rapid generation of several alleles of a target gene. Nucleic Acids Res, 2000, 28(21): E92.[7] Rickert RC, Roes J, Rajewsky K. B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res, 1997, 25(6): 1317-1318.[8] Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet, 1999, 21(1): 70-71.[9] Tsien JZ, Chen DF, Gerber D, Tom C, Mercer EH, Ander-son DJ, Mayford M, Kandel ER, Tonegawa S. Subregion- and cell type-restricted gene knockout in mouse brain. Cell, 1996, 87(7): 1317-1326.[10] Akagi K, Sandig V, Vooijs M, Van der Valk M, Giovannini M, Strauss M, Berns A. Cre-mediated somatic site-specific recombination in mice. Nucleic Acids Res, 1997, 25(9): 1766-1773.[11] Zinyk DL, Mercer EH, Harris E, Anderson DJ, Joyner AL. Fate mapping of the mouse midbrain-hindbrain constriction using a site-specific recombination system. Curr Biol, 1998, 8(11): 665-668.[12] Mao X, Fujiwara Y, Orkin SH. Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice. Proc Natl Acad Sci USA, 1999, 96(9): 5037-5042.[13] Lobe CG, Koop KE, Kreppner W, Lomeli H, Gertsenstein M, Nagy A. Z/AP, a double reporter for Cre-mediated re-combination. Dev Biol, 1999, 208(2): 281-292.[14] Michael SK, Brennan J, Robertson EJ. Efficient gene-specific expression of Cre recombinase in the mouse embryo by targeted insertion of a novel IRES-Cre cassette into endogenous loci. Mech Dev, 1999, 85(1-2): 35-47.[15] Novak A, Guo CY, Yang WY, Nagy A, Lobe CG. Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision. Genesis, 2000, 28(3-4): 147-155.[16] Kawamoto S, Niwa H, Tashiro F, Sano S, Kondoh G, Ta-keda J, Tabayashi K, Miyazaki J. A novel reporter mouse strain that expresses enhanced green fluorescent protein upon Cre-mediated recombination. FEBS Lett, 2000, 470(3): 263-268.[17] Mao XH, Fujiwara Y, Chapdelaine A, Yang HD, Orkin SH. Activation of EGFP expression by Cre-mediated excision in a new ROSA26 reporter mouse strain. Blood, 2001, 97(1): 324-326.[18] Huang ZJ, Yu W, Lovett C, Tonegawa S. Cre/loxP acti-vated neuronal markers in mouse neocortex and hippo-campus. Genesis, 2002, 32(3): 209-217.[19] Braz JM, Rico B, Basbaum AI. Transneuronal tracing of diverse CNS circuits by Cre-mediated induction of wheat germ agglutinin in transgenic mice. Proc Natl Acad Sci USA, 2002, 99(23): 15148-15153.[20] Vintersten K, Monetti C, Gertsenstein M, Zhang P, Laszlo L, Biechele S, Nagy A. Mouse in red: red fluorescent protein expression in mouse ES cells, embryos, and adult animals. Genesis, 2004, 40(4): 241-246.[21] Madisen L, Zwingman TA, Sunkin SM, Oh SW, Zariwala HA, Gu H, Ng LL, Palmiter RD, Hawrylycz MJ, Jones AR, Lein ES, Zeng HK. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci, 2010, 13(1): 133-140.[22] Badaloni A, Bonanomi D, Albieri I, Givogri I, Bongarzone E, Valtorta F, Consalez GG. Transgenic mice expressing a dual, CRE-inducible reporter for the analysis of axon guid-ance and synaptogenesis. Genesis, 2007, 45(6): 405-412.[23] Arenkiel BR, Klein ME, Davison IG, Katz LC, Ehlers MD. Genetic control of neuronal activity in mice conditionally expressing TRPV1. Nat Methods, 2008, 5(4): 299-302.[24] Braz JM, Rico B, Basbaum AI. Transneuronal tracing of diverse CNS circuits by Cre-mediated induction of wheat germ agglutinin in transgenic mice. Proc Natl Acad Sci USA, 2002, 99(23): 15148-15153.[25] Ishikawa TO, Herschman HR. Conditional bicistronic Cre reporter line expressing both firefly luciferase and β-galactosidase. Mol Imaging Biol, 2010, 13(2): 284-292.[26] Rodriguez CI, Dymecki SM. Origin of the precerebellar system. Neuron, 2000, 27(3): 475-486.[27] Awatramani R, Soriano P, Mai JJ, Dymecki S. An Flp indicator mouse expressing alkaline phosphatase from the ROSA26 locus. Nat Genet, 2001, 29(3): 257-259.[28] Possemato R, Eggan K, Moeller BJ, Jaenisch R, Jack-son-Grusby L. Flp recombinase regulated lacZ expression at the ROSA26 locus. Genesis, 2002, 32(2): 184-186.[29] Awatramani R, Soriano P, Rodriguez C, Mai JJ, Dymecki SM. Cryptic boundaries in roof plate and choroid plexus identified by intersectional gene activation. Nat Genet, 2003, 35(1): 70-75.[30] Yamamoto M, Shook NA, Kanisicak O, Yamamoto S, Wosczyna MN, Camp JR, Goldhamer DJ. A multifunctional reporter mouse line for Cre- and FLP-dependent lineage analysis. Genesis, 2009, 47(2): 107-114.[31] Livet J, Weissman TA, Kang H, Draft RW, Lu J, Bennis RA, Sanes JR, Lichtman JW. Transgenic strategies for combinatorial expression of fluorescent proteins in the nervous system. Nature, 2007, 450(7166): 56-62.[32] Srinivas S, Watanabe T, Lin CS, William CM, Tanabe Y, Jessell TM, Costantini F. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol, 2001, 1: 4.[33] Schmidt-Supprian M, Wunderlich FT, Rajewsky K. Exci-sion of the Frt-flanked neoR cassette from the CD19cre knock-in transgene reduces Cre-mediated recombination. Transgenic Res, 2007, 16(5): 657-660.[34] Opferman JT, Letai A, Beard C, Sorcinelli MD, Ong CC, Korsmeyer SJ. Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature, 2003, 426(6967): 671-676.[35] Thomas MD, Kremer CS, Ravichandran KS, Rajewsky K, Bender TP. c-Myb is critical for B cell development and maintenance of follicular B cells. Immunity, 2005, 23(3): 275-286.[36] Kmita M, Kondo T, Duboule D. Targeted inversion of a polar silencer within the HoxD complex re-allocates do-mains of enhancer sharing. Nat Genet, 2000, 26(4): 451-454.[37] Moon AM, Cappechi MR. Fgf8 is required for outgrowth and patterning of the limbs. Nat Genet, 2000, 26(4): 455-459.[38] Kraus M, Alimzhanov MB, Rajewsky N, Rajewsky K. Survival of resting mature B lymphocytes depends on BCR signaling via the Igα/β heterodimer. Cell, 2004, 117(6): 787-800.[39] Victoratos P, Lagnel J, Tzima S, Alimzhanov MB, Ra-jewsky K, Pasparakis M, Kollias G. FDC-specific functions of p55TNFR and IKK2 in the development of FDC networks and of antibody responses. Immunity, 2006, 24(1): 65-77.[40] Zabel MD, Weis JH. Cell-specific regulation of the CD21 gene. Int Immunopharmacol, 2001, 1(3): 483-493[41] Ma WB, Tessarollo L, Hong SB, Baba M, Southon E, Back TC, Spence S, Lobe CG, Sharma N, Maher GW, Pack S, Vortmeyer AO, Guo CF, Zbar B, Schmidt LS. Hepatic vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in mice with conditional inactivation of the VHL gene. Cancer Res, 2003, 63(17): 5320-5328.[42] Le DT, Kong N, Zhu Y, Lauchle JO, Aiyigari A, Braun BS, Wang E, Kogan SC, Le Beau MM, Parada L, Shannon KM. Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder. Blood, 2004, 103(11): 4243-4250.[43] Shibata H, Toyama K, Shioya H, Ito M, Hirota M, Hase-gawa S, Matsumoto H, Takano H, Akiyama T, Toyoshima K, Kanamaru R, Kanegae Y, Saito I, Nakamura Y, Shiba K, Noda T. Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science, 1997, 278(5335): 120-123.[44] Heinrich AC, Pelanda R, Klingmüller U. A mouse model for visualization and conditional mutations in the erythroid lineage. Blood. 2004, 104(3): 659-666.[45] Tsien JZ, Huerta PT, Tonegawa S. The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plas-ticity in spatial memory. Cell, 1996, 87(7): 1327-1338.[46] Minichiello L, Korte M, Wolfer D, Kühn R, Unsicker K, Cestari V, Rossi-Arnaud C, Lipp HP, Bonhoeffer T, Klein R. Essential role for TrkB receptors in hippocam-pus-mediated learning. Neuron, 1999, 24(2): 401-414.[47] Lomelí H, Ramos-Mejía V, Gertsenstein M, Lobe CG, Nagy A. Targeted insertion of Cre recombinase into the TNAP gene: excision in primordial germ cells. Genesis, 2000, 26(2): 116-117.[48] Ramirez A, Page A, Gandarillas A, Zanet J, Pibre S, Vidal M, Tusell L, Genesca A, Whitaker DA, Melton DW, Jor-cano JL. A keratin K5 Cre transgenic line appropriate for tissue-speci?c or generalized Cre-mediated recombination. Genesis, 2004, 39(1): 52-57.[49] Hayashi S, Tenzen T, McMahon AP. Maternal inheritance of Cre activity in a Sox2Cre deleter strain. Genesis, 2003, 37(2): 51-53.[50] Vincent SD, Robertson EJ. Highly effcient trans-gene-independent recombination directed by a maternally derived SOX2CRE transgene. Genesis, 2003, 37(2): 54-56.[51] Sakai K, Miyazaki J. A transgenic mouse line that retains Cre recombinase activity in mature oocytes irrespective of the cre transgene transmission. Biochem Biophys Res Commun, 1997, 237(2): 318-324.[52] Cochrane RL, Clark SH, Harris A, Kream BE. Rear-rangement of a conditional allele regardless of inheritance of a Cre recombinase transgene. Genesis, 2007, 45(1): 17-20.[53] Rassoulzadegan M, Grandjean V, Gounon P, Vincent S, Gillot I, Cuzin F. RNA-mediated non-mendelian inheri-tance of an epigenetic change in the mouse. Nature, 2006, 441(7092): 469-474.[54] Casola S, Cattoretti G, Uyttersprot N, Koralov SB, Seagal J, Hao ZY, Waisman A, Egert A, Ghitza D, Rajewsky K. Tracking germinal center B cells expressing germ-line immunoglobulin γ1 transcripts by conditional gene targeting. Proc Natl Acad Sci USA, 2006, 103(19): 7396-7401.[55] Hafner M, Wenk J, Nenci A, Pasparakis M, Scharffetter- Kochanek K, Smyth N, Peters T, Kess D, Holtkötter O, Shephard P, Kudlow JE, Smola H, Haase I, Schippers A, Krieg T, Müller W. Keratin 14 Cre transgenic mice authenticate keratin 14 as an oocyte-expressed protein. Genesis, 2004, 38(4): 176-181.[56] Hobeika E, Thiemann S, Storch B, Jumaa H, Nielsen PJ, Pelanda R, Reth M. Testing gene function early in the B cell lineage in mb1-cre mice. Proc Natl Acad Sci USA, 2006, 103(37): 13789-13794.[57] Wagner KU, McAllister K, Ward T, Davis B, Wiseman R, Hennighausen L. Spatial and temporal expression of the Cre gene under the control of the MMTV-LTR in different lines of transgenic mice. Transgenic Res, 2001, 10(6): 545-553.[58] Schmidt EE, Taylor DS, Prigge JR, Barnett S, Capecchi MR. Illegitimate Cre-dependent chromosome rearrangements in transgenic mouse spermatids. Proc Natl Acad Sci USA, 2000, 97(25): 13702-13707.[59] Thyagarajan B, Guimarães MJ, Groth AC, Calos MP. Mammalian genomes contain active recombinase recognition sites. Gene, 2000, 244(1-2): 47-54.[60] Semprini S, Troup TJ, Kotelevtseva N, King K, Davis JRE, Mullins LJ, Chapman KE, Dunbar DR, Mullins JJ. Cryptic loxP sites in mammalian genomes: genome-wide distribution and relevance for the efficiency of BAC/PAC recombineering techniques. Nucleic Acids Res, 2007, 35(5): 1402-1410.[61] Pfeifer A, Brandon EP, Kootstra N, Gage FH, Verma IM. Delivery of the Cre recombinase by a self-deleting lentiviral vector: efficient gene targeting in vivo. Proc Natl Acad Sci USA, 2001, 98(20): 11450-11455.[62] Silver DP, Livingston DM. Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity. Mol Cell, 2001, 8(1): 233-243.[63] de Alboran IM, O'Hagan RC, Gärtner F, Malynn B, Davidson L, Rickert R, Rajewsky K, DePinho RA, Alt FW. Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. Immunity, 2001, 14(1): 45-55.[64] Loonstra A, Vooijs M, Beverloo HB, Allak BA, van Drunen E, Kanaar R, Berns A, Jonkers J. Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proc Natl Acad Sci USA, 2001, 98(16): 9209-9214.[65] Baba Y, Nakano M, Yamada Y, Saito I, Kanegae Y. Practical range of effective dose for Cre recombinase- expressing recombinant adenovirus without cell toxicity in mammalian cells. Microbiol Immunol, 2005, 49(6): 559-570.[66] Mähönen AJ, Airenne KJ, Lind MM, Lesch HP, Ylä-Herttuala S. Optimized self-excising Cre-expression cassette for mammalian cells. Biochem Biophys Res Commun, 2004, 320(2): 366-371.[67] Jo D, Nashabi A, Doxsee C, Lin Q, Unutmaz D, Chen J, Ruley HE. Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase. Nat Biotechnol, 2001, 19(10): 929-933.[68] Patsch C, Edenhofer F. Conditional mutagenesis by cell-permeable proteins: potential, limitations and pros-pects. Handb Exp Pharmacol, 2007, (178): 203-232.[69] Peitz M, Pfannkuche K, Rajewsky K, Edenhofer F. Ability of the hydrophobic FGF and basic TAT peptides to pro-mote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomes. Proc Natl Acad Sci USA, 2002, 99(7): 4489-4494.[70] Peitz M, Jäger R, Patsch C, Jäger A, Egert A, Schorle H, Edenhofer F. Enhanced puri?cation of cell-permeant Cre and germline transmission after transduction into mouse embryonic stem cells. Genesis, 2007, 45(8): 508-517.[71] Patsch C, Peitz M, Otte DM, Kesseler D, Jungverdorben J, Wunderlich FT, Brüstle O, Zimmer A, Edenhofer F. Engineering cell-permeant FLP recombinase for tightly controlled inducible and reversible overexpression in embryonic stem cells. Stem Cells, 2010, 28(5): 894-902.[72] Heidmann D, Lehner CF. Reduction of Cre recombinase toxicity in proliferating Drosophila cells by estro-gen-dependent activity regulation. Dev Genes Evol, 2001, 211(8-9): 458-465.[73] Seibler J, Zevnik B, Küter-Luks B, Andreas S, Kern H, Hennek T, Rode A, Heimann C, Faust N, Kauselmann G, Schoor M, Jaenisch R, Rajewsky K, Kühn R, Schwenk F. Rapid generation of inducible mouse mutants. Nucleic Acids Res, 2003, 31(4): E12.[74] Higashi AY, Ikawa T, Muramatsu M, Economides AN, Niwa A, Okuda T, Murphy AJ, Rojas J, Heike T, Nakahata T, Kawamoto H, Kita T, Yanagita M. Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2. J Immunol, 2009, 182(9): 5633-5640.[75] Jullien N, Goddard I, Selmi-Ruby S, Fina JL, Cremer H, Herman JP. Conditional transgenesis using Dimerizable Cre (DiCre). PLoS One, 2007, 2(12): E1355.[76] Lee JY, Ristow M, Lin XY, White MF, Magnuson MA, Hennighausen L. RIP-Cre revisited, evidence for impair-ments of pancreatic β-cell function. J Biol Chem, 2006, 281(5): 2649-2653.[77] Sato S, Fujimoto M, Hasegawa M, Takehara K, Tedder TF. Altered B lymphocyte function induces systemic autoim-munity in systemic sclerosis. Mol Immunol, 2004, 41(12): 1123-1133.[78] Kwan KM. Conditional alleles in mice: practical consid-erations for tissue-speci?c knockouts. Genesis, 2002, 32(2): 49-62.[79] Zhao L, Bakke M, Krimkevich Y, Cushman LJ, Parlow AF, Camper SA, Parker KL. Hypomorphic phenotype in mice with pituitary-speci?c knockout of steroidogenic factor 1. Genesis, 2001, 30(2): 65-69.[80] Furuta Y, Behringer RR. Recent innovations in tissuespecific gene modifications in the mouse. Birth Defects Res C Embryo Today, 2005, 75(1): 43-57.[81] Naiche LA, Papaioannou VE. Cre activity causes wide-spread apoptosis and lethal anemia during embryonic development. Genesis, 2007, 45(12): 768-775.[82] Ryding AD, Sharp MG, Mullins JJ. Conditional transgenic technologies. J Endocrinol, 2001, 171(1): 1-14[83] Zhu Z, Ma B, Homer RJ, Zheng T, Elias JA. Use of the tetracycline controlled transcriptional silencer (tTS) to eliminate transgene leak in inducible overexpression trans-genic mice. J Biol Chem, 2001, 276(27): 25222-25229.[84] Tong C, Li P, Wu NL, Yan YZ, Ying QL. Production of p53 gene knockout rats by homologous recombination in embryonic stem cells. Nature, 2010, 467(7312): 211-213.[85] Eisener-Dorman AF, Lawrence DA, Bolivar VJ. Cautionary insights on knockout mouse studies: the gene or not the gene? Brain Behav Immun, 2009, 23(3): 318-324.[86] Ridgway WM, Healy B, Smink LJ, Rainbow D, Wicker LS. New tools for defining the ‘genetic background’of inbred mouse strains. Nat Immunol, 2007, 8(7): 669-673.[87] Schuster-Gossler K, Lee AW, Lerner CP, Parker HJ, Dyer VW, Scott VE, Gossler A, Conover JC. Use of coisogenic host blastocysts for efficient establishment of germline chimeras with C57BL/6J ES cell lines. Biotechniques, 2001, 31(5): 1022-1024, 1026.[88] Ledermann B, Burki K. Establishment of a germ-line competent C57BL/6 embryonic stem cell line. Exp Cell Res, 1991, 197(2): 254-258.[89] Seong E, Saunders TL, Stewart CL, Burmeister M. To knockout in 129 or in C57BL/6: that is the question. Trends Genet, 2004, 20(2): 59-62.[90] Sharova LV, Sharov AA, Piao Y, Shaik N, Sullivan T, Stewart CL, Hogan BL, Ko MS. Global gene expression profiling reveals similarities and differences among mouse pluripotent stem cells of different origins and strains. Dev Biol, 2007, 307(2): 446-459.[91] Hansen GM, Markesich DC, Burnett MB, Zhu Q, Dionne KM, Richter LJ, Finnell RH, Sands AT, Zambrowicz BP, Abuin A. Large-scale gene trapping in C57BL/6N mouse embryonic stem cells. Genome Res, 2008, 18(10): 1670-1679.[92] Austin CP, Battey JF, Bradley A, Bucan M, Capecchi M, Collins FS, Dove WF, Duyk G, Dymecki S, Eppig JT, Grieder FB, Heintz N, Hicks G, Insel TR, Joyner A, Koller BH, Lloyd KC, Magnuson T, Moore MW, Nagy A, Pollock JD, Roses AD, Sands AT, Seed B, Skarnes WC, Snoddy J, Soriano P, Stewart DJ, Stewart F, Stillman B, Varmus H, Varticovski L, Verma IM, Vogt TF, von Melchner H, Wit-kowski J, Woychik RP, Wurst W, Yancopoulos GD, Young SG, Zambrowicz B. The knockout mouse project. Nat Genet, 2004, 36(9): 921-924.[93] Mishina M, Sakimura K. Conditional gene targeting on the pure C57BL/6 genetic background. Neurosci Res, 2007, 58(2): 105-112.[94] Takeuchi T, Nomura T, Tsujita M, Suzuki M, Fuse T, Mori H, Mishina M. Flp recombinase transgenic mice of C57BL/6 strain for conditional gene targeting. Biochem Biophy Res Comm, 2002, 293(3): 953-957.[95] Gertsenstein M, Nutter LM, Reid T, Pereira M, Stanford WL, Rossant J, Nagy A. Efficient generation of germ line transmitting chimeras from C57BL/6N ES cells by aggregation with outbred host embryos. PLoS One, 2010, 5(6): E11260.[96] Jonkers J, Meuwissen R, van Der Gulden H, Peterse H, van der Valk M, Berns A. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet, 2001, 29(4): 418-425.[97] Mariani FV, Ahn CP, Martin GR. Genetic evidence that FGFs have an instructive role in limb proximal-distal patterning. Nature, 2008, 453(7193): 401-405.[98] Zhang Z, Lutz B. Cre recombinase-mediated inversion using lox66 and lox71: Method to introduce conditional point mutations into the CREB-binding protein. Nucleic Acids Res, 2002, 30(17): E90.[99] Terauchi Y, Sakura H, Yasuda K, Iwamoto K, Takahashi N, Ito K, Kasai H, Suzuki H, Ueda O, Kamada N, Jishage K, Komeda K, Noda M, Kanazawa Y, Taniguchi S, Miwa I, Akanuma Y, Kodama T, Yazaki Y, Kadowaki T. Pancreatic β-cell-speci?c targeted disruption of glucokinase gene. Diabetes mellitus due to defective insulin secretion to glu-cose. J Biol Chem, 1995, 270(51): 30253-30256.[100] Norris DP, Robertson EJ. Asymmetric and node-speci?c nodal expression patterns are controlled by two distinct cis-acting regulatory elements. Genes Dev, 1999, 13(12): 1575-1588.[101] Urnov FD, Miller JC, Lee YL, Beausejour CM, Rock JM, Augustus S, Jamieson AC, Porteus MH, Gregory PD, Holmes MC. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature, 2005, 435(7042): 646-651.[102] Urnov FD, Rebar EJ, Holmes MC, Zhang HS, Gregory PD. Genome editing with engineered zinc finger nucleases. Nat Rev Genet, 2010, 11(9): 636-646.[103] Anastassiadis K, Fu J, Patsch C, Hu SB, Weidlich S, Duerschke K, Buchholz F, Edenhofer F, Stewart AF. Dre recombinase, like Cre, is a highly efficient site-specific recombinase in E. coli, mammalian cells and mice. Dis Model Mech, 2009, 2(9-10): 508-515. |
| [1] | 田德桥，王玉民，郑涛. XerCD/dif位点特异性重组[J]. 遗传, 2012, 34(8): 1003-1008. |
| [2] | 龙定沛，谭兵，赵爱春，许龙霞，向仲怀. Cre/lox位点特异性重组系统在高等真核生物中的研究进展[J]. 遗传, 2012, 34(2): 177-189. |
| [3] | 徐焕宇，龚秀丽，郭歆冰，马晴雯，曾溢滔. 卵母细胞特异表达fC31整合酶载体pZP3-INT的构建及其在小鼠卵母细胞中的表达[J]. 遗传, 2009, 31(6): 595-599. |
| [4] | 薛可，李峰，罗光彬，黄玮玮，陈学进. 利用Red同源重组系统进行牛β酪蛋白基因敲除[J]. 遗传, 2007, 29(5): 570-570―574. |
| [5] | 滕艳，杨晓. 基因打靶技术：开启遗传学新纪元[J]. 遗传, 2007, 29(11): 1291-1298. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||
www.chinagene.cn
备案号：京ICP备09063187号-4
总访问:,今日访问:,当前在线:
